×
About 1,795 results

ALLMedicine™ Abdominal Abscess Center

Research & Reviews  412 results

Emergent Subtotal Colectomies Have Higher Leak Rates in Subsequent J-Pouch Stages.
https://doi.org/10.1007/s11605-023-05631-x
Journal of Gastrointestinal Surgery : Official Journal Of... Plietz MC, Coste M et. al.

Mar 14th, 2023 - The most common surgery for ulcerative colitis (UC) is the staged restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA). On occasion, an emergent first-stage subtotal colectomy must be performed. The purpose of this study was to com...

FDG-PET Imaging in Complicated Diabetic Foot
https://clinicaltrials.gov/ct2/show/NCT00194298

Mar 6th, 2023 - FDG-PET imaging is a promising imaging technique, which has the potential to overcome many of the shortcomings mentioned previously with regard to radiologic and scintigraphic methodologies. FDG is a diagnostic tracer utilized to measure the metab...

Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron d...
https://doi.org/10.1016/S2352-3026(22)00402-1
The Lancet. Haematology; Talboom K, Borstlap WAA et. al.

Mar 3rd, 2023 - A third of patients with colorectal cancer who are eligible for surgery in high-income countries have concomitant anaemia associated with adverse outcomes. We aimed to compare the efficacy of preoperative intravenous and oral iron supplementation ...

Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT03441893

Mar 3rd, 2023 - The prospective cohort and randomized, double-blind, placebo controlled study will be conducted on the basis of Research Institute of Epidemiology, Microbiology and Infectious Diseases and Coloproctology department of the Republic clinical hospita...

Surgical approaches to colonic and rectal anastomosis: systematic review and meta-analy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947093
International Journal of Colorectal Disease; Oliveira A, Faria S et. al.

Feb 23rd, 2023 - Postoperative complications after a colonic and rectal surgery are of significant concern to the surgical community. Although there are different techniques to perform anastomosis (i.e., handsewn, stapled, or compression), there is still no consen...

see more →

Drugs  229 results see all →

Clinicaltrials.gov  44 results

FDG-PET Imaging in Complicated Diabetic Foot
https://clinicaltrials.gov/ct2/show/NCT00194298

Mar 6th, 2023 - FDG-PET imaging is a promising imaging technique, which has the potential to overcome many of the shortcomings mentioned previously with regard to radiologic and scintigraphic methodologies. FDG is a diagnostic tracer utilized to measure the metab...

Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT03441893

Mar 3rd, 2023 - The prospective cohort and randomized, double-blind, placebo controlled study will be conducted on the basis of Research Institute of Epidemiology, Microbiology and Infectious Diseases and Coloproctology department of the Republic clinical hospita...

Efficacy of ABSOLOK™ Clip System-RFP-2021-01 in Open Liver Resection
https://clinicaltrials.gov/ct2/show/NCT05705557

Jan 31st, 2023 - Over the last two decades, significant advances have been made in hepatectomy because of advancements in surgical techniques and improvement on parenchymal transection. Modern liver surgeon must be equipped with excellent theoretical and clinical ...

Risk Factors for Clinically Relevant Postoperative Pancreatic Fistula
https://clinicaltrials.gov/ct2/show/NCT05687825

Jan 18th, 2023 - Pancreaticoduodenectomy (PD) procedure is one of the standard treatments for benign and malignant diseases of the periampullary region and head of the pancreas. However, PD is still technically challenging and has significant rates of morbidity (u...

Delayed Primary Closure Using Negative Pressure Wound Therapy
https://clinicaltrials.gov/ct2/show/NCT04042259

Jan 11th, 2023 - Surgical site infection rates for contaminated or dirty laparotomy wounds can be as high as 45%. Surgical management of dirty and contaminated wounds has been controversial in the literature and between surgeons. Primary closure (PC) of these woun...

see more →

News  30 results

Laparoscopic gastrectomy for gastric cancer: Postoperative NSAID use requires caution
https://www.mdedge.com/hematology-oncology/article/258993/gastrointestinal-cancer/laparoscopic-gastrectomy-gastric-cancer

Oct 26th, 2022 - Key clinical point: Postoperative nonsteroidal anti-inflammatory drug (NSAID) use in intravenous patient-controlled analgesia (IV-PCA) is associated with an increased risk for anastomotic leakage, duodenal stump leakage, intra-abdominal bleeding,.

Belzutifan Plus Cabozantinib Elicits High Response Rate in Treatment-Naïve Advanced Clear Cell RCC
https://www.onclive.com/view/belzutifan-plus-cabozantinib-elicits-high-response-rate-in-treatment-na-ve-advanced-clear-cell-rcc

Sep 16th, 2022 - Belzutifan (Welireg) plus cabozantinib (Cabometyx) was well tolerated and demonstrated promising antitumor activity in patients with treatment-naïve advanced clear cell renal cell carcinoma (RCC), according to findings from cohort 1 of the phase 2...

Second-Line RGX-202-01 Plus FOLFIRI/Bevacizumab Shows Early Efficacy, Safety in KRAS-Mutant CRC
https://www.onclive.com/view/second-line-rgx-202-01-plus-folfiri-bevacizumab-shows-early-efficacy-safety-in-kras-mutant-crc

Jun 29th, 2022 - A second-line combination regimen comprised of RGX-202-01, FOLFIRI (leucovorin, 5-fluouracil [5-FU], and irinotecan), and bevacizumab (Avastin) demonstrated an encouraging efficacy signal and a favorable toxicity profile in patients with KRAS-muta...

Encouraging evidence supports tofacitinib use in refractory pediatric IBD
https://www.mdedge.com/gihepnews/article/242150/ibd-intestinal-disorders/encouraging-evidence-supports-tofacitinib-use

Jun 24th, 2021 - Key clinical point: Tofacitinib induced rapid clinical response with sustained efficacy in nearly half of the pediatric and young adults with medically refractory inflammatory bowel disease (IBD) with a safety profile similar to that in adults. Ma.

Crizotinib Confirmed as Standard of Care for ALK+ Inflammatory Myofibroblastic Tumors
https://www.onclive.com/view/crizotinib-confirmed-as-standard-of-care-for-alk-inflammatory-myofibroblastic-tumors

Dec 20th, 2020 - Patrick Schöffski, MD, MPH Treatment with crizotinib (Xalkori) elicited an objective response rate (ORR) of 50% (95% CI, 21.1%-78.9%) for patients with ALK-positive advanced, inoperable inflammatory myofibroblastic tumor (IMT), according to findi...

see more →

Patient Education  3 results see all →